Clinical data
AHFS/ International Drug Names
ATC code B01AC15 (WHO) N02BA02 (WHO)
CAS Number 9014-67-9
PubChem (CID) 3032790
ChemSpider 2297682 YesY
KEGG D07421 YesY
Chemical and physical data
Formula C18H15AlO9
Molar mass 402.288 g/mol
3D model (Jmol) Interactive image

Aloxiprin (or aluminium acetylsalicylate) is a medical drug used for the treatment of pain and inflammation associated with muscular skeletal and joint disorders.[1] It is used for its properties as an anti-inflammatory, antipyretic and analgesic drug.[1] It is a chemical compound of aluminium hydroxide and aspirin.[2][3]

Alternative names and combinations



  1. 1 2 MIMS. "Aloxiprin". MIMS. Retrieved 16 April 2011.
  2. Encarta. "Aloxiprin". Encarta. Retrieved 16 April 2011.
  3. CUMMINGS AJ, MARTIN BK, WIGGINS LF (1963). "In vitro and in vivo properties of aloxiprin: a new aluminium derivative of acetylsalicylic acid". J. Pharm. Pharmacol. 15: 56–62. PMID 14024235.
  4. Geller J (1968). "A comparative trial of aloxiprin ('Palaprin Forte') and phenylbutazone ('Butazolidin')". The British journal of clinical practice. 22 (9): 392–4. PMID 4876729.
  5. Net Doctor UK. "Askit Powders". Treatments for joint, muscle and bone conditions. Retrieved 16 April 2011.

External links

This article is issued from Wikipedia - version of the 11/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.